Related Experiment Video
Updated: Sep 4, 2025
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
4.0K
To sell or not to sell: considerations when evaluating private equity acquisitions
Frini Makadia1, Jacob Roskam2, Ruth D Williams1
1Wheaton Eye Clinic.
Current Opinion in Ophthalmology
|July 15, 2022
Summary
Private practice ophthalmology groups considering private equity partnerships must analyze equity transition, growth, management, and sale impacts. These factors are crucial whether partnering with private equity or remaining independent.
Area of Science:
- Ophthalmology practice management
- Healthcare business strategy
- Private equity in healthcare
Background:
- Many private practice ophthalmology groups are exploring partnerships with private equity firms.
- This trend necessitates careful evaluation of practice viability and strategic alignment.
Purpose of the Study:
- To discuss critical factors for ophthalmology practices considering private equity acquisition.
- To guide practice leaders in evaluating independence versus partnership with an equity firm.
Main Methods:
- Review of strategic considerations for private practice acquisition models.
- Analysis of key issues in equity transition, management, and governance.
Main Results:
- Practices must analyze equity transition, continued growth strategies, organizational management, and post-sale effects.
- These considerations are vital regardless of the decision to partner with private equity or remain independent.
Conclusions:
- A thorough analysis of four key factors is essential for mature private practices contemplating private equity.
- Strategic planning for equity transition, growth, management, and sale implications is paramount for all private practices.
